Keros Therapeutics Inc (KROS)

Stock-Based Compensation

$5.38M

Quarterly · Period ending: · USD

KROS logo

KROS Stock-Based Compensation

Latest reported$5.38M
KROS Quarterly Stock-Based Comp ($11.00K → $5.38M)
High-resolution chart · PNG

KROS stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Keros Therapeutics Inc Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
5,377,000
6,199,000
7,305,000
3,986,000
8,542,000
8,863,000
9,200,000
8,817,000
8,785,000
8,070,000
7,324,000
8,711,000
7,041,000
5,687,000
4,746,000
4,754,000
4,794,000
4,388,000
3,295,000
3,084,000
2,849,000
2,494,000
1,522,000
1,424,000
1,139,000
12,000
18,000
17,000
13,000
11,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.